Sarcopenia, revised European diagnostic criteria 2018
Authors:
prof. MUDr. Topinková Eva, CSc.
Authors place of work:
Geriatrická klinika 1. LF UK a VFN Praha
Published in the journal:
Geriatrie a Gerontologie 2019, 8, č. 1: 14-19
Category:
Review Article
Summary
The paper presents the revised European consensus on definition and diagnosis of sarcopenia recommended by the European Working Group on Sarcopenia in Older People in 2018. Sarcopenia is defined as a progressive, generalized muscle disorder associated with a higher risk of negative health outcomes – falls, fractures, physical disability and mortality. Furthermore, the diagnostic algorithm for screening and diagnosis of sarcopenia is described in detail. The article provides a detailed review of screening and diagnostic methods and consensus-based cut off values.
Keywords:
revised criteria 2018 – musclemass, strength and function – clinical diagnosis
Zdroje
1. http://www.icd10data.com/ICD10CM/Codes/M00–M99/M60–M63/M62–/M62.84. 2018 ICD–10–CM DiagnosisCode M62.84.
2. Vellas B, Fielding RA, Bens C, et al. Implications of ICD-10 for sarcopenia clinical practice and clinical trials: report by the International Conference on Frailty and Sarcopenia Research Task Force. J Frailty Aging 2018;7: 2–9.
3. Topinková E. Sarkopenie jako závažné orgánové selhání, její diagnostika a současné možnosti léčby. Vnitř lék 2018, 64(11): 1038–1052.
4. Shafiee G, Keshtkar A, Soltani A, et al. Prevalence of sarcopenia in the world: a systematic review and meta analysis of general population studies. J Diabetes Metab Disord 2017;16(1): 21.
5. Steffl M, Sima J, Shiells K, Holmerova I. The increase in health care costs associated with muscle weakness in older people without long-term illnesses in the Czech Republic: results from the Survey of Health, Ageing and Retirement in Europe (SHARE). ClinInterv Aging 2017;12: 2003–2007.
6. Anker SD, Coats AJS, Morely JE, et al. Muscle wasting disease: A proposal for a new disease classification. J Cachexia Sarcopenia Muscle 2014; 5: 1–3
7. Cruz-Jentoft AJ, Baeyens JP, Bauer JM, et al. Sarcopenia: European consensus on definition and diagnosis: report of the European working group on sarcopenia in older people. Age Ageing 2010; 39: 412–423.
8. Fielding RA, Vellas B, Evans WJ, et al. Sarcopenia: an undiagnosed condition in older adults current consensus definition: prevalence, etiology, and consequences. International Working Group on Sarcopenia. J Am Med Dir Assoc 2011; 12: 249–256.
9. Morley JE, Abbatecola AM, Argiles JM, et al. Sarcopenia with limited mobility: an International Consensus. J Am Med Dir Assoc 2011; 12: 403–409.
10. Studenski SA, Peters KW, Alley DE, et al. The FNIH Sarcopenia Project: rationale, study description, conference recommendations, and final estimates. J Gerontol A Biol Sci Med Sci 2014; 69: 547–558.
11. Chen LK, Liu LK, Woo J, et al. Sarcopenia in Asia: consensus Report of the Asian Working Group for Sarcopenia. J Am Med Dir Assoc 2014; 15: 95–101.
12. Cruz-Jentoft AJ, Bahat G, Bauer J, et al. Sarcopenia: revised European consensus on definition and diagnosis. Age Ageing 2018, Oct 12.
13. Beaudart Ch, McCloskey E, Bruyere O, et al. Sarcopenia in daily practice: assessment and management. BMC Geriatrics 2016; 16: 170.
14. Muscaritoli M, Anker SD, Argiles J, et al. Consensus definition of sarcopenia, cachexia and pre-cachexia: joint document elaborated by Special Interest Groups (SIG) „cachexia-anorexia in chronic wasting diseases“ and „nutrition in geriatrics“. Clin Nutr 2010; 29: 154–159.
15. Steffl M, Bohannon RW, Sontakova L ,et al. Relationship between sarcopenia and physical activity in older people: a systematic review and meta-analysis. Clin Interv Aging 2017; 12: 835–845.
16. Vágnerová T. Nová kritéria pro diagnostiku malnutrice – co nám říkají? Geri a Gero 2019;8 (1): 20–25.
17. Prado CM, Wells JC, Smith SR, et al. Sarcopenic obesity: a critical appraisal of the current evidence. Clin Nutr 2012; 31: 583–601.
18. Cruz–Jentoft AJ, Landi F, Topinková E, et al. Understanding sarcopenia as a geriatric syndrome. Curr Opin Clin Nutr Metab Care 2010; 13: 1–7.
19. Ida S, Kaneko R, Murata K. SARC-F for screening of sarcopenia among alder adults: A meta–analysis of screening test accuracy. J Am Med Dir Assoc 2018; 19: 685–689.
20. Michálková H, Rýznarová I, Seget J, Topinková E. Hodnocení kvality života u pacientů vyššího věku se sarkopenií: vývoj a validace české verze dotazníku SarQoL. Geri a Gero 2017; 6 (1): 28–37.
21. Peel NM, Kuys SS, Klein K. Gait speed as a measure in geriatric assessment in clinical settings: a systematic review. J Gerontol A Biol Sci Med Sci 2013; 68: 39–46.
22. Berková M, Topinková E, Mádlová P, et al. Krátká baterie pro testování fyzické zdatnosti seniorů – pilotní studie a validizace testu u starších osob v České republice. Vnitř Lék 2013; 59: 256–263.
23. Bischoff HA, Stahelin HB, Monsch AU, et al. Identifying a cut–off point for normal mobility: a comparison of the timed up and go test in community-dwelling and institutionalised elderly women. Age Ageing 2003;32: 315–320
Štítky
Geriatrics General practitioner for adults Orthopaedic prostheticsČlánok vyšiel v časopise
Geriatrics and Gerontology
2019 Číslo 1
- Advances in the Treatment of Myasthenia Gravis on the Horizon
- Memantine Eases Daily Life for Patients and Caregivers
- Spasmolytic Effect of Metamizole
- Metamizole at a Glance and in Practice – Effective Non-Opioid Analgesic for All Ages
- What Effect Can Be Expected from Limosilactobacillus reuteri in Mucositis and Peri-Implantitis?
Najčítanejšie v tomto čísle
- Intravenous administration of hugh doses of vitamin C
- New criteria for diagnosis of malnutrition – what do they say?
- Sarcopenia, revised European diagnostic criteria 2018
- Statin therapy in elderly patients